FIELD: medicine.
SUBSTANCE: group of inventions relates to oncology, and can be used for treating cancer. For this purpose, a synthetic matrix metalloproteinase oligopeptide, consisting of one of amino acid sequences of SEQ ID NO:5-21, is used. Also proposed is a pharmaceutical composition for treating cancer, a method for producing a pharmaceutical composition, a method for treating a mammal, use of oligopeptide to produce a vaccine for producing an immune response to human matrix metalloproteinase-2 or human matrix metalloproteinase-9 in a mammal and use of oligopeptide for producing a vaccine for treating cancer.
EFFECT: group of inventions allows treating cancers in mammals.
19 cl, 4 tbl, 15 dwg
